Literature DB >> 11014971

Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects.

C P Mavragani1, A G Tzioufas, H M Moutsopoulos.   

Abstract

Autoantibodies to cellular autoantigens are usually found in sera of patients with systemic autoimmune rheumatic diseases. Patients with Sjögren's syndrome (SS) frequently present autoantibodies to both organ and non-organ-specific autoantigens. The most commonly detected autoantibodies are those directed against the ribonucleoproteins Ro/SSA and La/SSB. The presence of the antibodies in SS is associated with early disease onset, longer disease duration, parotid gland enlargement, higher frequency of extraglandular manifestations and more intense lymphocytic infiltration of the minor salivary glands. Over the past several years, the structure and function of these autoantigens have been extensively studied. Several centers, using different techniques, have investigated the B cell epitopes on the protein components Ro 60 kD, Ro 52kD, and La 48 kD. Finally, increased evidence of direct involvement of anti-Ro/SSA and anti-La/SSB autoantibodies in the pathogenesis of tissue injury has been contributed by several studies. Copyright 2000 S. Karger AG, Basel .

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11014971     DOI: 10.1159/000024423

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  20 in total

Review 1.  Immunopathogenesis of Sjögren's syndrome.

Authors:  Andrea T Borchers; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

2.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 3.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

4.  Active immunological profile is associated with systemic Sjögren's syndrome.

Authors:  Clothilde Martel; Guillaume Gondran; David Launay; Fabrice Lalloué; Sylvain Palat; Marc Lambert; Kim Ly; Veronique Loustaud-Ratti; Holly Bezanahary; Eric Hachulla; Marie Odile Jauberteau; Elisabeth Vidal; Pierre Yves Hatron; Anne Laure Fauchais
Journal:  J Clin Immunol       Date:  2011-07-09       Impact factor: 8.317

5.  SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus.

Authors:  O Billaut-Mulot; C Cocude; V Kolesnitchenko; M J Truong; E K Chan; E Hachula; X de la Tribonnière; A Capron; G M Bahr
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

6.  Prevalence of Novel Candidate Sjögren Syndrome Autoantibodies in the Penn Sjögren's International Collaborative Clinical Alliance Cohort.

Authors:  Vatinee Y Bunya; Mina Massaro-Giordano; Frederick B Vivino; Maureen G Maguire; Alan N Baer; John A Gonzales; Gui-Shuang Ying
Journal:  Cornea       Date:  2019-12       Impact factor: 2.651

7.  Quantitative salivary gland scintigraphy can distinguish patients with primary Sjøgren's syndrome during the evaluation of sicca symptoms.

Authors:  Anne Marthe Henriksen; Hans C Nossent
Journal:  Clin Rheumatol       Date:  2007-02-21       Impact factor: 2.980

8.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30

9.  T cell help is required to induce idiotypic-anti-idiotypic autoantibody network after immunization with complementary epitope 289-308aa of La/SSB autoantigen in non-autoimmune mice.

Authors:  M G Papamattheou; J G Routsias; E E Karagouni; C Sakarellos; M Sakarellos-Daitsiotis; H M Moutsopoulos; A G Tzioufas; E N Dotsika
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

10.  Prevalence of Novel Candidate Sjogren Syndrome Autoantibodies in the Dry Eye Assessment and Management (DREAM) Study.

Authors:  Vatinee Y Bunya; Gui-Shuang Ying; Maureen G Maguire; Eric Kuklinski; Meng C Lin; Ellen Peskin; Penny A Asbell
Journal:  Cornea       Date:  2018-11       Impact factor: 2.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.